Table 1.
Author, year | Study period | Study area (site) | Sample size | Sample types (Culture specimens) |
No. of Gram-negative isolates | No. of ESBL (%) |
---|---|---|---|---|---|---|
Abayneh M et al., 2018 [32] | March to June 2016 | Jimma | 342 | urine | 74 | 17 (23.0) |
Abera B et al., 2016 [33] | Sept 2013 to March 2015 | Bahir Dar | 477 | blood, urine, pus/swab and body fluids | 210 | 120 (57.1) |
Beyene G et al., 2011 [21] | Jan to Aug. 2006 | Addis Ababa | 1225 | stool, blood | 113 | 78 (69.0) |
Desta K et al., 2016 [22] | 10–20 Dec 2012 | Addis Ababa | 267 | stool | 295 | 151 (51.2) |
Eugale T et al., 2018 [23] | April 2013 to March 2014 | Addis Ababa | 68 | Stool | 68 | 12 (17.6) |
Gashaw M et al., 2018 [24] | May to Sept. 2016 | Jimma | 197 | urine, swab/pus, blood, and sputum | 100 | 36 (36.0) |
Legese et al., 2017 [25] | Jan. to March 2014 | Addis Ababa | 322 | blood and urine | 28 | 22 (78.6) |
Mulisa et al., 2015 [26] | April to Aug. 2016 | Adama | 384 | urine, stool, swabs, and body fluids | 65 | 17 (26.0) |
Mulualem Y et al., 2012 [27] | Feb. to March 2007 | Jimma | 359 | urine, stool, swabs, and sputum | 67 | 24 (35.8) |
Pritsch M et al., 2017 [28] | Jan. 2014 to June 2015 | Jimma | 224 | swabs and body fluids | 14 | 3 (21.4) |
Seboxa T et al., 2015 [29] | Aug. 2012 and Oct. 2013. | Addis Ababa | 292 | blood | 20 | 9 (45.0) |
Seid & Asrat, 2005 [30] | Dec. 2003 to Feb. 2004 | Harar | 384 | sputum, urine and pus | 57 | 19 (33.3) |
Teklu DS et al., 2019 [31] | Jan. to May 2017 | Addis Ababa | 426 | urine, blood, swabs, and body fluids | 426 | 246 (57.7) |
Zeynudin A et al., 2018 [8] | March to Oct. 2014 | Jimma | 224 | urine, swabs, blood and fluids | 112 | 71 (63.4) |